AL
ANIP icon

Airain Ltd’s ANI Pharmaceuticals ANIP Stock Holding History

Airain Ltd’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-14,725
Closed -$582K – 819
2015
Q3 		$582K Sell
14,725
-4,236
-22% -$241K 0.03% 437
2015
Q2 		$1.18M Buy
+18,961
New +$1.13M 0.07% 306
2014
Q4 		– Sell
-9,521
Closed -$269K – 695
2014
Q3 		$269K Buy
9,521
+3,452
+57% +$103K 0.02% 608
2014
Q2 		$209K Buy
+6,069
New +$190K 0.02% 657

Other funds holding ANIP

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

Airain Ltd's ANIP Position: Q4 2015 in Review

Airain Ltd sold out of ANI Pharmaceuticals (ANIP) in Q4 2015, closing a stake of 14,725 shares — an estimated $582K sold.

Airain Ltd first reported a position in ANIP in Q2 2014 and held it in 4 quarters. The position peaked at $1.18M in Q2 2015. 123 funds tracked by Wall St. Rank hold ANIP as of Q4 2015.

  • Airain Ltd reported no remaining ANI Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Airain Ltd sold 14,725 ANI Pharmaceuticals shares in Q4 2015, an estimated $582K.
  • Airain Ltd first reported a position in ANI Pharmaceuticals in Q2 2014 and held it in 4 quarters.
  • Airain Ltd's ANI Pharmaceuticals position peaked at $1.18M in Q2 2015.
  • 123 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q4 2015.

Based on Airain Ltd's 13F filing for Q4 2015, filed 11 Feb 2016.